Brevan Howard Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
138,304
+84,282
| +156% | +$755K | 0.01% | 876 |
|
|
2025
Q1 | $405K | Sell |
54,022
-2,622
| -5% | -$19.7K | ﹤0.01% | 729 |
|
|
2024
Q4 | $426K | Sell |
56,644
-22,824
| -29% | -$172K | ﹤0.01% | 634 |
|
|
2024
Q3 | $604K | Sell |
79,468
-14,999
| -16% | -$114K | ﹤0.01% | 576 |
|
|
2024
Q2 | $584K | Buy |
94,467
+81,968
| +656% | +$507K | 0.01% | 504 |
|
|
2024
Q1 | $63.5K | Sell |
12,499
-57,592
| -82% | -$293K | ﹤0.01% | 880 |
|
|
2023
Q4 | $420K | Buy |
+70,091
| New | +$420K | 0.01% | 517 |
|